Literature DB >> 29729099

An evidence-based approach to assessing surgical versus clinical diagnosis of symptomatic endometriosis.

Hugh S Taylor1, G David Adamson2, Michael P Diamond3, Steven R Goldstein4, Andrew W Horne5, Stacey A Missmer6,7, Michael C Snabes8, Eric Surrey9, Robert N Taylor10.   

Abstract

Challenges intrinsic to the accurate diagnosis of endometriosis contribute to an extended delay between the onset of symptoms and clinical confirmation. Intraoperative visualization, preferably with histologic verification, is considered by many professional organizations to be the gold standard by which endometriosis is diagnosed. Clinical diagnosis of symptomatic endometriosis via patient history, physical examination, and noninvasive tests, though more easily executed, is generally viewed as less accurate than surgical diagnosis. Technological advances and increased understanding of the pathophysiology of endometriosis warrant continuing reevaluation of the standard method for diagnosing symptomatic disease. A review of the published literature was therefore performed with the goal of comparing the accuracy of clinical diagnostic measures with that of surgical diagnosis. The current body of evidence suggests that clinical diagnosis of symptomatic endometriosis is more reliable than previously recognized and that surgical diagnosis has limitations that could be underappreciated. Regardless of the methodology used, women with suspected symptomatic endometriosis would be well served by a diagnostic paradigm that is reliable, conveys minimal risk of under- or over-diagnosis, lessens the time from symptom development to diagnosis, and guides the appropriate use of medical and surgical management strategies.
© 2018 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  Diagnosis; Endometriosis; Histology; Infertility; Laparoscopy; Pelvic examination; Pelvic pain; Surgery

Mesh:

Year:  2018        PMID: 29729099     DOI: 10.1002/ijgo.12521

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  19 in total

1.  Dose-Dependent Decreased Fertility in Response to the Burden of Endometriosis in a Murine Model.

Authors:  Ana C J S Rosa-E-Silva; Julio C Rosa-E-Silva; Ramanaiah Mamillapalli; Hugh S Taylor
Journal:  Reprod Sci       Date:  2019-07-05       Impact factor: 3.060

2.  Antibody Arrays Identified Cycle-Dependent Plasma Biomarker Candidates of Peritoneal Endometriosis.

Authors:  Maja Pušić; Teja Klančič; Tamara Knific; Andrej Vogler; Ronny Schmidt; Christoph Schröder; Tea Lanišnik Rižner
Journal:  J Pers Med       Date:  2022-05-24

3.  Evaluation of Soluble CD90: Potential for Diagnostic Significance in Endometriosis Patients.

Authors:  Ivan M Bochev; Iliya I Karagyozov; Nadya M Magunska; Vesselina S Koleva; Ivan V Krumov; Elena S Puncheva; Georgi P Boyadzhiev; Kameliya Vinketova; Milena S Mourdjeva; Tsvetelina P Oreshkova
Journal:  Dis Markers       Date:  2022-06-20       Impact factor: 3.464

4.  Presurgical blood metabolites and risk of postsurgical pelvic pain in young patients with endometriosis.

Authors:  Naoko Sasamoto; Oana A Zeleznik; Allison F Vitonis; Stacey A Missmer; Marc R Laufer; Julian Avila-Pacheco; Clary B Clish; Kathryn L Terry
Journal:  Fertil Steril       Date:  2022-03-30       Impact factor: 7.490

Review 5.  An Evidence-Based Review of Elagolix for the Treatment of Pain Secondary to Endometriosis.

Authors:  Ivan Urits; Leena Adamian; Paulo Miro; Jessica Callan; Parth M Patel; Megha Patel; Amnon A Berger; Hisham Kassem; Alan D Kaye; Omar Viswanath
Journal:  Psychopharmacol Bull       Date:  2020-10-15

6.  Endometriosis: A Malignant Fingerprint.

Authors:  Christopher DeAngelo; Megan Burnett Tarasiewicz; Athena Strother; Heather Taggart; Caron Gray; Meaghan Shanahan; Christopher Glowacki; Jimmy Khandalavala; Erin Talaska; Andrea Kinnan; John Joseph Coté; Adrienne Perfilio Edwards; Gina Harper-Harrison; Murray Joseph Casey; Traci-Lynn Hirai; Sarah Schultz; Lynnea Stines; Roma Vora; Dominique Boudreau; Jennifer Burgart; Meredith Shama; Trevor Watson; Lisa Strasheim; Rachel Thompson; Rachel Lawlor; Kayleen Joyce; Claire M Magnuson; Jane Driano; Breanna Elger; Anne Lentino; Margaret Driscoll; Elise Tidwell; Apoorva Sharma; Sarah R Walker; Gretchen Jones; Poonam Sharma; Holly Stessman; Yanyuan Wu; Jay Vadgama; Dana Chase; Lesley Conrad; Srinivasa T Reddy; Robin Farias-Eisner
Journal:  J Cancer Res Ther Oncol       Date:  2020-12-29

7.  Plasma High Mobility Group Box 1 (HMGB1), Osteopontin (OPN), and Hyaluronic Acid (HA) as Admissible Biomarkers for Endometriosis.

Authors:  Yunlei Cao; Xishi Liu; Sun-Wei Guo
Journal:  Sci Rep       Date:  2019-06-25       Impact factor: 4.379

8.  Technical Verification and Assessment of Independent Validation of Biomarker Models for Endometriosis.

Authors:  Dorien F O; Amelie Fassbender; Rita Van Bree; Annouschka Laenen; Daniëlle P Peterse; Arne Vanhie; Etienne Waelkens; Thomas M D'Hooghe
Journal:  Biomed Res Int       Date:  2019-07-25       Impact factor: 3.411

Review 9.  Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment.

Authors:  Edgardo Rolla
Journal:  F1000Res       Date:  2019-04-23

10.  Pelvic floor, abdominal and uterine tenderness in relation to pressure pain sensitivity among women with endometriosis and chronic pelvic pain.

Authors:  Amy L Shafrir; Elena Martel; Stacey A Missmer; Daniel J Clauw; Steven E Harte; Sawsan As-Sanie; Christine B Sieberg
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2021-07-22       Impact factor: 2.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.